Atlas Trials

Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

Clinical trial NCT01539707 · COMPLETED

Trial details

NCT number
NCT01539707
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Overactive BladderNeurogenic Detrusor Overactivity
Start date
2012-03-13
Primary completion
2012-08-13
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.